SCHEMBL14472938

SCHEMBL14472938

Nc1cc(NP)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20621084 0.78 — —
SCHEMBL18879039 0.76 — —
SCHEMBL1060179 0.66 — —
Hydrochloric Acid SCHEMBL10688336 0.64 — —
Hydrochloric Acid SCHEMBL6618909 0.64 — —
SCHEMBL9933191 0.62 — —
SCHEMBL14080654 0.62 — —
SCHEMBL17950341 0.60 — —
Hydrochloric Acid SCHEMBL9739519 0.60 — —
Hydrochloric Acid SCHEMBL17942045 0.59 TDP1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145009-A1 HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEFUL FOR TREATING VARIOUS CANCERS EFFECTOR THERAPEUTICS, INC. 2017-05-25 — — US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 — — US disclosed
Send feedback